Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram
Cureus | The Cost-Effectiveness of and Adherence to Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis Patients in a Tertiary Care Teaching Hospital in Uttarakhand, India | Article
Rheumatoid Arthritis: Aggressive New Treatment Guidelines
JCM | Free Full-Text | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology
Emerging Treatments for Rheumatoid Arthritis: Update | Consultant360
Disease-modifying antirheumatic drugs - ScienceDirect
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms | Annals of the Rheumatic Diseases
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea | Rheumatology and Therapy
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan | springermedizin.de
Disease-modifying antirheumatic drugs | Download Table
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Traditional disease-modifying antirheumatic drugs (DMARDs) | Download Table
Frontiers | The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Drugs used for arthritis. Conventional Disease Modifying Anti-Rheumatic... | Download Scientific Diagram
Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis | Annals of the Rheumatic Diseases
Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis
Small Molecule DMARD Therapy and Its Position in RA Treatment | IntechOpen
Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect
:max_bytes(150000):strip_icc()/dmards-5200573_final-d7a3435040364245b453126ef7ee6572.jpg "DMARDs for Rheumatoid Arthritis: Types, Uses, Dosages,")
DMARDs for Rheumatoid Arthritis: Types, Uses, Dosages,
Treatment of Juvenile Idiopathic Arthritis | Pediatric Annals
Disease-Modifying Antirheumatic Drug - an overview | ScienceDirect Topics
